chartexchange

SPRY
ARS Pharmaceuticals, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:58 PM EST
3.70USD+1.370%(+0.05)1,695,694
Pre-marketNov 18, 2026 8:35:30 AM EST
3.50USD-4.110%(-0.15)
After-hoursNov 18, 2026 4:00:30 PM EST
3.69USD-0.270%(-0.01)

SPRY Financials

In Q3 FY 2026 (ended ), ARS Pharmaceuticals, Inc. Common Stock (SPRY) reported revenue of $37.71M, net income of −$35.59M, operating cash flow of −$33.71M, and assets of $251.48M (filed ).

Loading business breakdowns…